Eight-year follow-up study of bromocriptine monotherapy for parkinson’s disease

European Neurology

Volumn 36, Issue , 1996, Pages 32-37

  Tashiro, K ^a   Goto, I ^b   Kanazawa, I ^c   Kowa, H ^d   Kuno, S ^e   Mizuno, Y ^f   Ogawa, N ^g   Yanagisawa, N ^h  

^a HOKKAIDO UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d KITASATO UNIVERSITY HOSPITAL   (Japan)

^e UTANO NATIONAL HOSPITAL   (Japan)

^f JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g OKAYAMA UNIVERSITY   (Japan)

^h SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bromocriptine; Collaborative study; Dopamine receptor agonist; Monotherapy; Multicentric

Indexed keywords

BROMOCRIPTINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

ADULT; AGED; CLINICAL TRIAL; CONFERENCE PAPER; DETERIORATION; FEMALE; FOLLOW UP; HUMAN; JAPAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PARKINSON DISEASE; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; ANTIPARKINSON AGENTS; BROMOCRIPTINE; DISEASE PROGRESSION; DOPAMINE AGONISTS; DRUG THERAPY, COMBINATION; DYSKINESIA, DRUG-INDUCED; FEMALE; FOLLOW-UP STUDIES; HUMANS; JAPAN; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE;

EID: 0030051633     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000118881     Document Type: Article

References (7)

1. Nakanishi T, Iwata M, Goto I, Kanazawa I, Kowa H, Hannen T, Mizuno Y, Nishitani H, Ogawa N, Takahashi A, Tashiro K, Tohgi H, Yanagisawa N: Nationwide collaborative study on the long-term effects of bromocriptine in the treatment of parkinsonian patients. Final report. Eur Neurol 1992:32(suppl 1):9-22.
2. Yanagisawa N, Kanazawa I, Goto I, Kowa H, Kuno S, Mizuno Y, Tashiro K, Ogawa N: Seven-year follow-up study of bromocriplone therapy for Parkinson’s disease. Eur Neurol 1994: 34(suppl 3):29-35.
3. Yoshikawa T, Minamiyama Y, Naito Y, Kondo M: Antioxidant properties of bromocriptone. a dopamine agonist. J Neurochcm 1994:62:1034-1038.
4. Ogawa N, Tanaka K, Asanuma M, Kawai M, Masumizu T, Kohno M, Mori A: Bromocriptone protects mice against 6-hydroxydropamine and scavenges hydroxyl free radicals in vitro. Brain Res 1994:657(12):207-213.
5. Liu XH, Kato H, Chen T, Kato K, Itoyama Y: Bromocriptine protects against delayed neuronal death of hippocampal neurons following cerebral ischemia in the gerbil. J Neurol Sci 1995;129:9-14.
6. Swanson PD: Drug treatment of Parkinson's disease: Is ‘polypharmacy’ best? J Neurol Neu-rosurg Psychiatry 1994;57:401-403.
7. Montastruc JL, Rascol O, Senard JM, Rascol A: A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson’s disease: A five year follow up. J Neurol Neurosurg Psychiatry 1994;57:1034-1038.